Acinetobacter baumannii, a prominent pathogen responsible for chronic infections in the
blood, urinary tract, and lungs, has a high mortality due to its virulence and limited …

Acinetobacter baumannii is emerging as a serious nosocomial pathogen with multidrug
resistance that has made it difficult to cure and development of efficacious treatment against …

Acinetobacter baumannii is one of the major pathogenic ESKAPE bacterium, which is
responsible for about more than 722,000 cases in a year, globally. Despite the alarming …

Antibiotic resistance (AR) is the result of microbes' natural evolution to withstand the action
of antibiotics used against them. AR is rising to a high level across the globe, and novel …

Acinetobacter baumannii is notorious for causing serious infections of the skin, lungs, soft
tissues, bloodstream, and urinary tract. Despite the overwhelming information available so …

AIM To design a multi-epitope assembly peptide (MEP) of Acinetobacter baumannii and
evaluate its immunogenicity and protective immunity in Balb/c mice. METHODS The T-and B …

Vaccines and monoclonal antibodies are promising approaches for preventing and treating
infections caused by multidrug resistant Acinetobacter baumannii. However, only partial …

Pneumonia is a major endemic disease around the world, and an effective vaccine is the
need of the hour to fight against the disease. When there are no appropriate antiviral and …

Background Acinetobacter baumannii has emerged as a significant nosocomial pathogen
during the last few years, exhibiting resistance to almost all major classes of antibiotics …

The emergence of drug-resistant Acinetobacter baumannii is the global health problem
associated with high mortality and morbidity. Therefore it is high time to find a suitable …